| | | | | | | Sponsored | Our Novaplex™ respiratory panel assays can test for the most prevalent respiratory pathogens including bacteria and viruses, across multiple sample types. For research use only. |
|
|
| | |
| |
|
|
|
| | | | | The Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) announced the launch of Impact Wellbeing. This new campaign provides hospital leaders with evidence-informed resources to improve workplace policies and practices that reduce burnout, normalize help-seeking, and strengthen professional wellbeing. |
|
|
| | |
| |
|
|
|
| | | | Sponsored | | EUROIMMUN takes a holistic approach in addressing the issues of IFA testing. They offer customized solutions to combine services, products, and support, as well as high quality lab automation. For example, the upcoming UNIQO 160 provides a walkaway IFA process for 160 samples per run to encourage better multi-tasking and ensure labs can meet growing demands efficiently. |
|
|
| | |
| |
|
|
|
| | | | | The U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR) announced a settlement under the Health Insurance Portability and Accountability Act (HIPAA) with Doctors’ Management Services, a Massachusetts medical management company that provides a variety of services, including medical billing and payor credentialing. |
|
|
| | |
| |
|
|
|
| | | | | OncoHost has developed a novel computational model for predicting significant immune-related adverse events (irAEs) in patients with non-small cell lung cancer (NSCLC) based on proteomic profiling of pre-treatment blood samples. The study was conducted using OncoHost’s PROphet platform and will be presented as a poster at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting. |
|
|
| | |
| |
|
|
|
| | | | | Most people who have mild cognitive impairment (MCI) don’t know it, so they’re unable to take advantage of preventive measures or new treatments, such as a recently approved drug for Alzheimer’s disease, that could slow its progression. Those are the findings of two new studies published in parallel by researchers at the USC Dornsife College of Letters, Arts and Sciences. |
|
|
| | |
| |
|
|
|
| | | | | The U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. |
|
|
| | |
| |
|
|
|
| | | | | Lab professionals turn to MLO for unbiased answers, with more than 50 years of excellence in peer-reviewed editorial.
This is a great time to subscribe!
Your November 2023 issue of MONTHLY MAGAZINE is now available online. View >>
SUBSCRIBE to more leading edge content from our digital edition! CLR - Annual Buyer's Guide |
| | |
| |
|
|
|
| | |
|
| | |
|
